125 related articles for article (PubMed ID: 37689367)
1. Quantification of anti-drug antibodies against E6011, an anti-fractalkine monoclonal antibody, in monkey and human serum, by an electrochemiluminescence assay.
Aoyama M; Mano Y
J Pharmacol Toxicol Methods; 2023; 124():107470. PubMed ID: 37689367
[TBL] [Abstract][Full Text] [Related]
2. Application of an electrochemiluminescence assay for quantification of E6011, an antifractalkine monoclonal antibody, to pharmacokinetic studies in monkeys and humans.
Aoyama M; Mano Y
J Clin Lab Anal; 2019 Jan; 33(1):e22625. PubMed ID: 30030862
[TBL] [Abstract][Full Text] [Related]
3. An electrochemiluminescence assay for quantification of Denileukin Diftitox and its anti-drug antibodies in rat serum.
Mano Y
J Pharmacol Toxicol Methods; 2023; 119():107239. PubMed ID: 36526166
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics, Pharmacodynamics, and Safety of E6011, a Novel Humanized Antifractalkine (CX3CL1) Monoclonal Antibody: A Randomized, Double-Blind, Placebo-Controlled Single-Ascending-Dose Study.
Tabuchi H; Katsurabara T; Mori M; Aoyama M; Obara T; Yasuda N; Kawano T; Imai T; Ieiri I; Kumagai Y
J Clin Pharmacol; 2019 May; 59(5):688-701. PubMed ID: 30575978
[TBL] [Abstract][Full Text] [Related]
5. A phase 2 study of E6011, an anti-Fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to biological disease-modifying antirheumatic drugs.
Tanaka Y; Takeuchi T; Yamanaka H; Nanki T; Umehara H; Yasuda N; Tago F; Kitahara Y; Kawakubo M; Torii K; Hojo S; Kawano T; Imai T
Mod Rheumatol; 2021 Jul; 31(4):783-789. PubMed ID: 33427546
[TBL] [Abstract][Full Text] [Related]
6. Safety, pharmacokinetics, and efficacy of E6011, an antifractalkine monoclonal antibody, in a first-in-patient phase 1/2 study on rheumatoid arthritis.
Tanaka Y; Takeuchi T; Umehara H; Nanki T; Yasuda N; Tago F; Kawakubo M; Kitahara Y; Hojo S; Kawano T; Imai T
Mod Rheumatol; 2018 Jan; 28(1):58-65. PubMed ID: 28681650
[TBL] [Abstract][Full Text] [Related]
7. Long-term evaluation of E6011, an anti-fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to biological disease-modifying antirheumatic drugs.
Tanaka Y; Takeuchi T; Yamanaka H; Nanki T; Umehara H; Yasuda N; Tago F; Kitahara Y; Kawakubo M; Torii K; Hojo S; Kawano T; Imai T
Mod Rheumatol; 2023 Dec; 34(1):45-49. PubMed ID: 36680420
[TBL] [Abstract][Full Text] [Related]
8. An electrochemiluminescence (ECL)-based assay for the specific detection of anti-drug antibodies of the IgE isotype.
Wu Y; Liu X; Chen Y; Woods R; Lee N; Yang H; Chowdhury P; Roskos LK; White WI
J Pharm Biomed Anal; 2013 Dec; 86():73-81. PubMed ID: 23988731
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of E6011, an Anti-Fractalkine Monoclonal Antibody, in Patients With Active Rheumatoid Arthritis With Inadequate Response to Methotrexate: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Study.
Tanaka Y; Takeuchi T; Yamanaka H; Nanki T; Umehara H; Yasuda N; Tago F; Kitahara Y; Kawakubo M; Torii K; Hojo S; Kawano T; Imai T
Arthritis Rheumatol; 2021 Apr; 73(4):587-595. PubMed ID: 33038062
[TBL] [Abstract][Full Text] [Related]
10. A systematic study of the effect of low pH acid treatment on anti-drug antibodies specific for a domain antibody therapeutic: Impact on drug tolerance, assay sensitivity and post-validation method assessment of ADA in clinical serum samples.
Kavita U; Duo J; Crawford SM; Liu R; Valcin J; Gleason C; Dong H; Gadkari S; Dodge RW; Pillutla RC; DeSilva BS
J Immunol Methods; 2017 Sep; 448():91-104. PubMed ID: 28625864
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity screening assay development for a novel human-mouse chimeric anti-CD147 monoclonal antibody (Metuzumab).
Mi L; Li W; Li M; Chen T; Wang M; Sun L; Chen Z
J Immunol Methods; 2016 Jun; 433():38-43. PubMed ID: 26944771
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodies.
Stubenrauch K; Wessels U; Essig U; Vogel R; Schleypen J
J Pharm Biomed Anal; 2010 Jun; 52(2):249-54. PubMed ID: 20083366
[TBL] [Abstract][Full Text] [Related]
13. Phase 1 study on the safety and efficacy of E6011, antifractalkine antibody, in patients with Crohn's disease.
Matsuoka K; Naganuma M; Hibi T; Tsubouchi H; Oketani K; Katsurabara T; Hojo S; Takenaka O; Kawano T; Imai T; Kanai T
J Gastroenterol Hepatol; 2021 Aug; 36(8):2180-2186. PubMed ID: 33599356
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the ELISA and ECL Assay for Vedolizumab Anti-drug Antibodies: Assessing the Impact on Pharmacokinetics and Safety Outcomes of the Phase 3 GEMINI Trials.
Wyant T; Yang L; Rosario M
AAPS J; 2020 Nov; 23(1):3. PubMed ID: 33200296
[TBL] [Abstract][Full Text] [Related]
15. Strategy and validation of a nonclinical generic plug-and-play antidrug antibody method for human monoclonal antibody biotherapeutics.
Polsky R; Gunn G; Reese KJ; Hottenstein CS; Gehman A; Schwartz A; Root D; Concannon A
Bioanalysis; 2024 Mar; 16(5):277-287. PubMed ID: 38334073
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of an ADA-Tolerant Assay for Quantification of an Exatecan-Based ADC in Monkey Plasma.
Tao Y; Lu W; Gao J; Yang S; Ruan C; Hou Y; Lu J; Xu J; Zhang J; Pasas-Farmer S; Qin Q; Gong L
Molecules; 2024 Jan; 29(3):. PubMed ID: 38338316
[TBL] [Abstract][Full Text] [Related]
17. Comparison of different immunoassay methods to detect human anti-drug antibody using the WHO erythropoietin antibody reference panel for analytes.
Shibata H; Nishimura K; Miyama C; Tada M; Suzuki T; Saito Y; Ishii-Watabe A
J Immunol Methods; 2018 Jan; 452():73-77. PubMed ID: 28970009
[TBL] [Abstract][Full Text] [Related]
18. Two validated liquid chromatography-mass spectrometry methods with different pretreatments for the quantification of an anti-CD47 monoclonal antibody in rat and cynomolgus monkey serum compared with an electrochemiluminescence method.
Gao Y; Zhang D; Yang C; Duan X; Li X; Zhong D
J Pharm Biomed Anal; 2019 Oct; 175():112792. PubMed ID: 31377653
[TBL] [Abstract][Full Text] [Related]
19. A novel homogeneous Biotin-digoxigenin based assay for the detection of human anti-therapeutic antibodies in autoimmune serum.
Qiu ZJ; Ying Y; Fox M; Peng K; Lewin-Koh SC; Coleman D; Good J; Lowe J; Rahman A; Yang J; Jiang J; Quarmby V; Song A
J Immunol Methods; 2010 Oct; 362(1-2):101-11. PubMed ID: 20868690
[TBL] [Abstract][Full Text] [Related]
20. An innovative method for characterizing neutralizing antibodies against antibody-derived therapeutics.
Coddens A; Snoeck V; Bontinck L; Buyse MA; Pine SO
J Immunol Methods; 2020 Dec; 487():112896. PubMed ID: 33065122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
